UNSPSC 85594774: Insertion of intraluminal device into duodenum, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to insertion of intraluminal device into duodenum, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DH97DZ

UNSPSC 85594774, Insertion of intraluminal device into duodenum via natural or artificial opening, is a Commodity code that shows little relevant recent state and local procurement activity. The code's nominal scope — a highly specialized gastrointestinal procedure — does not align with the recent opportunities tagged under it in state and local solicitation databases. The posted opportunities instead cover occupational medical surveillance, disability medical evaluations, surgical benefit carve-outs for government employee health plans, pharmacy benefit management, temporary health professional staffing, emergency medical services for detained youth, and specialty center-of-excellence networks. None of these solicitations involve intraluminal duodenal devices or related procedural equipment or supplies. The mismatch reflects a tagging error in the underlying procurement system rather than active state and local purchasing in this medical device category.

The six recent opportunities posted under this code between July and September 2026 span Arizona (Phoenix), California (Long Beach and Santa Clara County), Washington State (ferries system), Florida (Collier County), and Texas (Harris County), suggesting either systematic miscategorization across multiple jurisdictions or limited uptake of this UNSPSC code for its intended purpose. No evidence of actual device procurement, bundled procedure packages, or gastrointestinal supply contracts appears in the record. Business development professionals should verify code application with target procurement offices before investing in pursuit strategy, as the current activity under this Commodity code does not reflect purchasing aligned with the code's medical device scope.